Schulhoff & Co Inc
- SEC CIK
- 0001080197
- Latest filing
- Aug 13, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Schulhoff & Co Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 22,499
- Value
- $2.04M
- % of portfolio
- 0.8%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 22,499 | $2.04M | 0.8% | −1,345−5.6% | Reduced | Holders |
| Q1 2026 | 23,844 | $2.45M | 1.0% | 00.0% | Unchanged | Holders |
| Q4 2025 | 23,844 | $2.99M | 1.3% | −52−0.2% | Reduced | Holders |
| Q3 2025 | 23,896 | $3.20M | 1.4% | 00.0% | Unchanged | Holders |
| Q2 2025 | 23,896 | $3.25M | 1.4% | −700−2.8% | Reduced | Holders |
| Q1 2025 | 24,596 | $3.26M | 1.4% | −300−1.2% | Reduced | Holders |
| Q4 2024 | 24,896 | $2.82M | 1.3% | −1,040−4.0% | Reduced | Holders |
| Q3 2024 | 25,936 | $2.96M | 1.2% | −80−0.3% | Reduced | Holders |
| Q2 2024 | 26,016 | $2.70M | 1.2% | −1,085−4.0% | Reduced | Holders |
| Q1 2024 | 27,101 | $3.08M | 1.3% | +70+0.3% | Added | Holders |
| Q4 2023 | 27,031 | $2.98M | 1.4% | −100−0.4% | Reduced | Holders |
| Q3 2023 | 27,131 | $2.63M | 1.3% | −1,240−4.4% | Reduced | Holders |
| Q2 2023 | 28,371 | $3.09M | 1.4% | −465−1.6% | Reduced | Holders |
| Q1 2023 | 28,836 | $2.92M | 1.4% | 00.0% | Unchanged | Holders |
| Q4 2022 | 28,836 | $3.17M | 1.5% | −500−1.7% | Reduced | Holders |
| Q3 2022 | 29,336 | $2.84M | 1.5% | −250−0.8% | Reduced | Holders |
| Q2 2022 | 29,586 | $3.21M | 1.5% | +50+0.2% | Added | Holders |
| Q1 2022 | 29,536 | $3.50M | 1.5% | +100+0.3% | Added | Holders |
| Q4 2021 | 29,436 | $4.14M | 1.7% | −305−1.0% | Reduced | Holders |
| Q3 2021 | 29,741 | $3.51M | 1.6% | +340+1.2% | Added | Holders |
| Q2 2021 | 29,401 | $3.41M | 1.5% | +1,227+4.4% | Added | Holders |
| Q1 2021 | 28,174 | $3.38M | 1.5% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.